Institute for International Research

	Co-located Events Same venue, shared exhibits, networking & partnering More information cGMP for Biologics - Asia Pacific Practices & Retrospective Tuesday, October 21, 2008 More information

Keynotes

Why is Ranbaxy's Deal with Daiichi Sankyo Transformational?
Malviner Singh, Chief Executive Officer, Ranbaxy, India

Zydus' Drug Discovery Engine and Pipeline as an Example of India's Move to Innovation in Drug Development
Pankaj Patel, Managing Director, Zydus Cadila, India

Glenmark's NCE Infrastructure for Innovation and Success at International Partnerships
Glenn Saldanha, Managing Director and CEO, Glenmark Pharmaceuticals, India

Attend this event and benefit from:

• Strategies and Technologies to Accelerate from Discovery to POC
• Explore Scientific Innovation from Indian Pharmas, Biotechs and Institutes
• Build Your Portfolio in Metabolic Syndrome, Cancer, CNS, and Inflammation
• Evaluate the Investment & Regulatory Landscape for Drug Development in India
• Partnering System to Find Research Collaborators and New Molecules

IBC's 5th Annual Drug Discovery and Development of Innovative Therapeutics INDIA conference and exhibition has a completely new focus in 2008. We're bringing together CEOs, therapeutic area experts, top scientists, R&D heads, investors, regulatory experts and business executives from India, the USA and Europe to share new technologies, novel targets, scientific strategies, exciting molecules, portfolio-building approaches and partnering strategies in metabolic disease, cancer, CNS and inflammation. Find out how other companies approach drug discovery and development for the global marketplace in the following areas:

• Developing an Innovative R&D Infrastructure, Therapeutic Area Expertise and Partnerships
• The Critical Path: Biomarkers and Early POC Strategies to Improve Clinical Outcomes
• Metabolic Disease: Diabetes, Translational Medicine and CADD Approaches
• Oncology: Multiple Myeloma, Aurora Kinases and Human-Tissue Models
• Inflammation: Systems Biology, Novel Targets and Inhibitors

You will also learn about multiple business models, and partnering strategies to help you identify potential collaborators, assets and investment opportunities. Drug discovery and development is a global endeavor conducted across many geographies, in multiple time zones and very often with multiple partners and collaborators. By attending this event you'll meet companies from around the world and hear concrete strategies to:

• Expand your Global R&D Efforts and Partnering Network
• Capitalize on India's Evolution from Drug Discovery Services to R&D Innovation and Therapeutics
• Navigate the Funding, Investment and Regulatory Framework for Drug Development
• Benefit from Risk-Share, Collaborative R&D and Licensing Deals to Build a Portfolio
• Find New Molecules and Scientific Technologies

Don't miss insights from the CEOs of Ranbaxy, Glenmark and Zydus Cadila, three of India's top R&D companies.

Take advantage of the 1-on-1 partnering system that allows you to pre-schedule meetings with other pre-registered attendees and speakers.